Genentech, Inc.

METHOD TO IDENTIFY A PATIENT WITH AN INCREASED LIKELIHOOD OF RESPONDING TO AN ANTI-CANCER THERAPY

Anti-CD22 antibodies and immunoconjugates and methods of use

METHOD FOR TREATING INTRAOCULAR NEOVASCULAR DISEASES

HARVEST OPERATIONS FOR RECOMBINANT PROTEINS

HUMANIZED ANTI-EGFL7 ANTIBODIES AND METHODS USING SAME

METHODS OF TREATING TUMORS

ANTI-NOTCH2 NRR ANTIBODIES

METHOD TO IDENTIFY A PATIENT WITH AN INCREASED LIKELIHOOD OF RESPONDING TO AN ANTI-CANCER THERAPY

METHOD TO IDENTIFY A PATIENT WITH AN INCREASED LIKELIHOOD OF RESPONDING TO AN ANTI-CANCER THERAPY

Methods for viral inactivation and other adventitious agents

Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy

Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy

METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF CANCER

Anti-FGFR3 antibodies and methods using same

Pyrido[3,2-d]pyrimidine PI3K delta inhibitor compounds and methods of use

METHODS AND COMPOSITIONS FOR DIAGNOSTIC USE IN CANCER PATIENTS

METHODS AND COMPOSITIONS FOR DIAGNOSTIC USE IN CANCER PATIENTS

Recombinant production of vascular endothelial growth factor

Antibodies to hepatocyte growth factor activator

Tricyclic compounds and methods of use therefor

METHODS OF USING CDK8 ANTAGONISTS

BIOLOGICAL MARKERS FOR IDENTIFYING PATIENTS FOR TREATMENT WITH VEGF ANTAGONISTS

Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof

Methods and compositions for protein labelling

COMPOSITION AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR

R-SPONDIN TRANSLOCATIONS AND METHODS USING THE SAME

TREATMENT WITH ANTI-ErbB2 ANTIBODIES